HomeCompareVICI vs HOLX

VICI vs HOLX: Dividend Comparison 2026

VICI yields 6.57% · HOLX yields 2.65%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VICI wins by $965.2K in total portfolio value
10 years
VICI
VICI Properties Inc.
● Live price
6.57%
Share price
$27.12
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$988.8K
Annual income
$623,261.32
Full VICI calculator →
HOLX
HOLX
● Live price
2.65%
Share price
$75.55
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.6K
Annual income
$314.03
Full HOLX calculator →

Portfolio growth — VICI vs HOLX

📍 VICI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVICIHOLX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VICI + HOLX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VICI pays
HOLX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VICI
Annual income on $10K today (after 15% tax)
$558.67/yr
After 10yr DRIP, annual income (after tax)
$529,772.12/yr
HOLX
Annual income on $10K today (after 15% tax)
$225.02/yr
After 10yr DRIP, annual income (after tax)
$266.93/yr
At 15% tax rate, VICI beats the other by $529,505.20/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VICI + HOLX for your $10,000?

VICI: 50%HOLX: 50%
100% HOLX50/50100% VICI
Portfolio after 10yr
$506.2K
Annual income
$311,787.67/yr
Blended yield
61.59%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+16.5% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
HOLX
Analyst Ratings
18
Buy
23
Hold
1
Sell
Consensus: Hold
Price Target
$77.80
+3.0% upside vs current
Range: $76.00 — $79.00
Altman Z
4.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VICI buys
11
HOLX buys
0
PoliticianChamberTickerTypeAmountDate
Ro Khanna🏢 House$VICI▲ Buy$1,001 - $15,0002024-10-14
Ro Khanna🏢 House$VICI▲ Buy$1,001 - $15,0002024-03-25
Ro Khanna🏢 House$VICI▼ Sell$1,001 - $15,0002024-03-20
Ro Khanna🏢 House$VICI▼ Sell$1,001 - $15,0002024-02-13
Ro Khanna🏢 House$VICI▼ Sell$1,001 - $15,0002023-11-03
Ro Khanna🏢 House$VICI▲ Buy$1,001 - $15,0002023-10-10
Ro Khanna🏢 House$VICI▼ Sell$1,001 - $15,0002023-09-06
Ro Khanna🏢 House$VICI▲ Buy$1,001 - $15,0002023-08-29
Ro Khanna🏢 House$VICI▲ Buy$1,001 - $15,0002023-07-28
Ro Khanna🏢 House$VICI▲ Buy$1,001 - $15,0002023-06-29
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVICIHOLX
Forward yield6.57%2.65%
Annual dividend / share$1.78$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR44.3%0%
Portfolio after 10y$988.8K$23.6K
Annual income after 10y$623,261.32$314.03
Total dividends collected$948.4K$2.9K
Payment frequencyquarterlyquarterly
SectorREITHealthcare
Analyst consensusBuyHold
Analyst price target$31.60$77.80

Year-by-year: VICI vs HOLX ($10,000, DRIP)

YearVICI PortfolioVICI Income/yrHOLX PortfolioHOLX Income/yrGap
1← crossover$11,368$948.43$10,965$264.73+$403.00VICI
2$13,339$1,493.16$12,004$271.27+$1.3KVICI
3$16,326$2,426.21$13,121$277.55+$3.2KVICI
4$21,123$4,112.15$14,323$283.54+$6.8KVICI
5$29,379$7,368.23$15,615$289.27+$13.8KVICI
6$44,804$14,191.64$17,003$294.73+$27.8KVICI
7$76,658$29,972.12$18,493$299.93+$58.2KVICI
8$150,894$71,015.81$20,093$304.87+$130.8KVICI
9$350,814$193,582.47$21,809$309.57+$329.0KVICI
10$988,809$623,261.32$23,649$314.03+$965.2KVICI

VICI vs HOLX: Complete Analysis 2026

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →

HOLXHealthcare

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Full HOLX Calculator →
📬

Get this VICI vs HOLX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VICI vs OVICI vs NNNVICI vs EPRTVICI vs ADCVICI vs STAGVICI vs SCHDVICI vs JEPIVICI vs KO

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.